Current trends in the composition of infant milk formulas

Current Paediatrics

Volumn 14, Issue 1, 2004, Pages 51-63

  Alles, Martine S ^a   Scholtens, Petra A M J ^a   Bindels, Jacques G ^a  

^a NUMICO RESEARCH   (Netherlands)

Author keywords

Formula; Hydrolysed protein; Infant; Long chain polyunsaturated fatty acid; Nucleotide; Prebiotic; Probiotic; Soy protein; Synthetic triacylglycerol

Indexed keywords

LIPID; LONG CHAIN FATTY ACID; NUCLEOTIDE DERIVATIVE; OLIGOSACCHARIDE; PALMITIC ACID; POLYUNSATURATED FATTY ACID; PREBIOTIC AGENT; PROBIOTIC AGENT; PROTEIN DERIVATIVE; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ARTIFICIAL MILK; FOOD COMPOSITION; FOOD QUALITY; FOOD SAFETY; INFANT NUTRITION; REVIEW;

EID: 1542359027     PISSN: 09575839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cupe.2003.09.007     Document Type: Review

References (123)

1. Cesar JA, Victora CG, Barros FC, Santos IS, Flores JA. Impact of breastfeeding on admission for pneumonia during postneonatal period in Brazil: nested case-control study. BMJ 1999;318(7194):1316-20.
2. Plank SJ, Milanesi ML. Infant feeding and infant mortality in rural Chile. Bull World Health Organ 1973;48(2):203-10.
3. Raisler J, Alexander C, O'Campo P. Breast-feeding and infant illness: a dose-response relationship? Am J Public Health 1999;89(1):25-30.
4. Wilson AC, Forsyth JS, Greene SA, Irvine L, Hau C, Howie PW. Relation of infant diet to childhood health: seven year follow up of cohort of children in dundee infant feeding study. BMJ 1998;316(7124):21-5.
5. European Commission. Commission Directive of 14 May 1991 on infant formulae and follow-on formulae (91/321/EEC). OJ L 175, p 35, last consolidated 25 May 1999.
6. Anderson JW, Johnstone BM, Remley DT. Breast-feeding and cognitive development: a meta analysis. Am J Clin Nutr 1999;70(4):525-35.
7. Koletzko B, Rodriguez-Palmero M. Polyunsaturated fatty acids in human milk and their role in early infant development. J Mammary Gland Biol Neoplasia 1999;4(3): 269-84.
8. Harzer G, Haug M, Dieterich I, Gentner PR. Changing patterns of human milk lipids in the course of the lactation and during the day. Am J Clin Nutr 1983;37(4):612-21.
9. Wang L, Shimizu YKaneko S, et al. Comparison of the fatty acid composition of total lipids and phospholipids in breast milk from Japanese women. Pediatr Int 2000;42(1):14-20.
10. Bitman J, Wood DL, Mehta NR, Hamosh P, Hamosh M. Comparison of the phospholipid composition of breast milk from mothers of term and preterm infants during lactation. Am J Clin Nutr 1984;40(5):1103-19.
11. Wijendran V, Huang MC, Diau GY, Boehm G, Nathanielsz PW, Brenna JT. Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates. Pediatr Res 2002; 51(3):265-72.
12. Wijendran V, Lawrence P, Diau GY, Boehm G, Nathanielsz PW, Brenna JT. Significant utilization of dietary arachidonic acid is for brain adrenic acid in baboon neonates. J Lipid Res 2002;43(5):762-7.
13. SanGiovanni JP, Parra-Cabrera S, Colditz GA, Berkey CS, Dwyer JT. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 2000;105(6):1292-8.
14. SanGiovanni JP, Berkey CS, Dwyer JT, Colditz GA. Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infants: a systematic review. Early Hum Dev 2000;57(3): 165-88.
15. Hoffman DR, Birch EE, Birch DG, et al. Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development. J Pediatr Gastroenterol Nutr 2000;31(5):540-53.
16. Makrides M, Neumann MA, Simmer K, Gibson RA. A critical appraisal of the role of dietary long-chain polyunsaturated fatty acids on neural indices of term infants: a randomized, controlled trial. Pediatrics 2000;105(1 Part 1):32-8.
17. Birch EE, Hoffman DR, Castaneda YS, Fawcett SL, Birch DG, Uauy RD. A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am J Clin Nutr 2002;75(3):570-80.
18. O'Connor DL, Hall R, Adamkin D, et al. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 2001;108(2):359-71.
19. Lucas A, Stafford M, Morley R, et al. Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-formula milk: a randomized trial. Lancet 1999;354(9194):1948-54.
20. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 2000;42(3): 174-81.
21. Fewtrell MS, Morley R, Abbott RA, et al. Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula-fed to preterm infants. Pediatrics 2002;110(1 Part 1):73-82.
22. Willatts P, Forsyth JS, DiModugno MK, Varma S, Colvin M. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 1998;352(9129):688-91.
23. Koletzko B, Agostoni C, Carlson SE, et al. Long-chain polyunsaturated fatty acids (LC-PUFA) and perinatal development. Acta Paediatr 2001;90(4):460-4.
24. Morley R, Abbott RA, Lucas A. Infant feeding and maternal concerns about stool hardness. Child Care Health Dev 1997;23(6):475-8.
25. Quinlan PT, Lockton S, Irwin J, Lucas AL. The relationship between stool hardness and stool composition in breast- and formula-fed infants. J Pediatr Gastroenterol Nutr 1995;20(1):81-90.
26. Weaver LT, Ewing G, Taylor LC. The bowel habit of milk-fed infants. J Pediatr Gastroenterol Nutr 1988;7(4):568-71.
27. Carnielli VP, Luijendijk IH, van Goudoever JB, et al. Feeding premature newborn infants palmitic acid in amounts and stereoisomeric position similar to that of human milk: effects on fat and mineral balance. Am J Clin Nutr 1995;61(5):1037-42.
28. Carnielli VP, Luijendijk IH, van Goudoever JB, et al. Structural position and amount of palmitic acid in infant formulas: effects on fat, fatty acid, and mineral balance. J Pediatr Gastroenterol Nutr 1996;23(5):553-60.
29. Kennedy K, Fewtrell MS, Morley R, et al. Double-blind, randomized trial of a synthetic triacylglycerol in formula-fed term infants: effects on stool biochemistry, stool characteristics, and bone mineralization. Am J Clin Nutr 1999;70(5):920-7.
30. Fomon SJ, Thomas LN, Filer Jr, LJ, Anderson TA, Bergmann KE. Requirements for protein and essential amino acids in early infancy. Studies with a soy-isolate formula. Acta Paediatr Scand 1973;62(1):33-45.
31. Butte NF, Garza C, Smith EO, Nichols BL. Human milk intake and growth in exclusively breast-fed infants. J Pediatr 1984;104(2):187-95.
32. Janas LM, Picciano MF, Hatch TF. Indices of protein metabolism in term infants fed human milk, whey-predominant formula, or cows' milk formula. Pediatrics 1985;75(4):775-84.
33. Salmenpera L, Perheentupa J, Siimes MA. Exclusively breast-fed healthy infants grow slower than reference infants. Pediatr Res 1985;19(3):307-12.
34. Raiha N, Minoli I, Moro G. Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatr Scand 1986;75:881-6.
35. Picone TA. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentration similar to human milk. J Pediatr Gastroenterol Nutr 1989;9:351-60.
36. Axelsson IE, Jakobsson I, Raiha N. Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatr Res 1988;24(3):297-301.
37. Fomon SJ, Ziegler EE, Nelson SE, Frantz JA. What is the safe protein-energy ratio for infant formulas. Am J Clin Nutr 1995;62:358-63.
38. Fomon SJ, Ziegler EE, Nelson SE, Rogers RR, Frantz JA. Infant formula with protein-energy ratio of 1.7 g/100 kcal is adequate but may not be safe. J Pediatr Gastroenterol Nutr 1999;28:495-501.
39. Ziegler EE, Carrie-Fassler A, Haschke F, Nelson SE, Jeter JM. Modified whey formula with protein-energy ratio 1.8g/100 kcal: metabolic balance studies in infants. J Pediatr Gastroenterol Nutr 2000;31(Suppl 2):S173.
40. Raiha NC, Fazzolari-Nesci A, Cajozzo C, et al. Whey predominant, whey modified infant formula with protein/energy ratio of 1.8 g/100 kcal: adequate and safe for term infants from birth to four months. J Pediatr Gastroenterol Nutr 2002;35(3):275-81.
41. Host A, Koletzko B, Dreborg S, et al. Dietary products used in infants for treatment and prevention of food allergy. Joint Statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition. Arch Dis Child 1999;81(1):80-4.
42. Lucassen PL, Assendelft WJ, Gubbels JW, van Eijk JT, Douwes AC. Infantile colic: crying time reduction with a whey hydrolysate: a double-blind, randomized, placebo-controlled trial. Pediatrics 2000;106(6):1349-54.
43. Rigo J, Salle BL, Picaud JC, Putet G, Senterre J. Nutritional evaluation of protein hydrolysate formulas. Eur J Clin Nutr 1995;49(Suppl. 1):S26.
44. Mihatsch WA, Pohlandt F. Protein hydrolysate formula maintains homeostasis of plasma amino acids in preterm infants. J Pediatr Gastroenterol Nutr 1999;29(4):406-10.
45. Szajewska H, Albrecht P, Stoitiska B, Prochowska A, Gawecka A, Laskowska-Klita T. Extensive and partial protein hydrolysate preterm formulas: the effect on growth rate, protein metabolism indices, and plasma amino acid concentration. J Pediatr Gastroenterol Nutr 2001;32(3):303-9.
46. Picaud JC, Rigo J, Normand S, et al. Nutritional efficacy of preterm formula with a partially hydrolyzed protein source: a randomized pilot study. J Pediatr Gastroenterol Nutr 2001;32(5):555-61.
47. Mihatsch WA, Hogel J, Pohlandt F. Hydrolysed protein accelerates the gastrointestinal transport of formula in preterm infants. Acta Paediatr 2001;90(2):196-8.
48. Mihatsch WA, Franz AR, Högel J, Pohlandt F. Hydrolyzed protein accelerates feeding advancement in very low birth weight infants. Pediatrics 2002;116(6):1199-203.
49. Zeiger RS, Sampson HA, Bock SA, et al. Soy allergy in infants and children with IgE-associated cows' milk allergy. J Pediatr 1999;134(5):614-22.
50. Host A. Cows' milk protein allergy and intolerance in infancy. Some clinical, epidemiological and immunological aspects. Pediatr Allergy Immunol 1994;5(5 Suppl):1-36.
51. Burks AW, Casteel HB, Fiedorek SC, Williams LW, Pumphrey CL. Prospective oral food challenge study of two soybean protein isolates in patients with possible milk or soy protein enterocolitis. Pediatr Allergy Immunol 1994;5(1):40-5.
52. American Academy of Pediatrics. Committee on Nutrition. Soy protein-based formulas: recommendations for use in infant feeding. Pediatrics 1998;101(1 Part 1):148-53.
53. Hill DJ, Davidson GP, Cameron DJ, Barnes GL. The spectrum of cows' milk allergy in childhood. Clinical, gastroenterological and immunological studies. Acta Paediatr Scand 1979;68(6):847-52.
54. Bock SA, Atkins FM. Patterns of food hypersensitivity during sixteen years of double-blind, placebo-controlled food challenges. J Pediatr 1990;117(4):561-7.
55. Ragno V, Giampietro PG, Bruno G, Businco L. Allergenicity of milk protein hydrolysate formulae in children with cows' milk allergy. Eur J Pediatr 1993;152(9):760-2.
56. Businco L, Bruno G, Giampietro PG. Soy protein for the prevention and treatment of children with cow-milk allergy. Am J Clin Nutr 1998;68(6 Suppl):1447S-52S.
57. Irvine C, Fitzpatrick M, Robertson I, Woodhams D. The potential adverse effects of soybean phytoestrogens in infant feeding. N Z Med J 1995;108(1000):208-9.
58. Barnes S. Evolution of the health benefits of soy isoflavones. Proc Soc Exp Biol Med 1998;217(3):386-92.
59. Slavin JL. Phytoestrogens in breast milk-another advantage of breast feeding? Clin Chem 1996;42(6 Part 1):841-2.
60. Irvine CH, Shand N, Fitzpatrick MG, Alexander SL. Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas. Am J Clin Nutr 1998;68(6 Suppl):1462S-5S.
61. Shemesh M, Lindner HR, Ayalon N. Affinity of rabbit uterine oestradiol receptor for phyto-oestrogens and its use in a competitive protein-binding radioassay for plasma coumestrol. J Reprod Fertil 1972;29(1):1-9.
62. Shutt DA, Cox RI. Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. J Endocrinol 1972;52(2): 299-310.
63. Mathieson RA, Kitts WD. Binding of phyto-oestrogen and oestradiol-17 beta by cytoplasmic receptors in the pituitary gland and hypothalamus of the ewe. J Endocrinol 1980; 85(2):317-25.
64. Setchell KD, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 1984;40(3): 569-78.
65. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994; 60(3):333-40.
66. Essex C. Phytoestrogens and soy based infant formula. BMJ 1996;313(7056):507-8.
67. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996;87(5 Part 2): 897-904.
68. Klein KO. Isoflavones, soy-based infant formulas, and relevance to endocrine function. Nutr Rev 1998;56(7): 193-204.
69. Strom BL, Schinnar R, Ziegler EE, et al. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. JAMA 2001;286(7): 807-14.
70. Cruz ML, Wong WW, Mimouni F, et al. Effects of infant nutrition on cholesterol synthesis rates. Pediatr Res 1994; 35(2):135-40.
71. European Commission Scientific Committee on Food. Report of the scientific committee on food on the revision of essential requirements of infant formulae and follow-on formulae. SCF/CS/NUT/IF/65 Final. 18 May 2003.
72. Janas LM, Picciano MF. The nucleotide profile of human milk. Pediatr Res 1982;16(8):659-62.
73. Thorell L, Sjoberg LB, Hernell O. Nucleotides in human milk: sources and metabolism by the newborn infant. Pediatr Res 1996;40(6):845-52.
74. Barness LA. Dietary sources of nucleotides-from breast milk to weaning. J Nutr 1994;124(1 Suppl):128S-30S.
75. Cosgrove M. Perinatal and infant nutrition. Nucleotides. Nutrition 1998;14(10):748-51.
76. Sanderson IR, He Y. Nucleotide uptake and metabolism by intestinal epithelial cells. J Nutr 1994;124(1 Suppl):131S-7S.
77. Yu VY. The role of dietary nucleotides in neonatal and infant nutrition. Singapore Med J 1998;39(4):145-50.
78. Jyonouchi H. Nucleotide actions on humoral immune responses. J Nutr 1994;124(1 Suppl):138S-43S.
79. Uauy R. Dietary nucleotides and requirements in early life. In: Lebenthal, editor. Textbook of gastroenterology and nutrition in infancy. 2nd ed. New York: Raven Press, 1989, p. 265-80.
80. Cosgrove M, Davies DP, Jenkins HR. Nucleotide supplementation and the growth of term small for gestational age infants. Arch Dis Child Fetal Neonatal Ed 1996;74(2):F122.
81. Carver JD, Pimentel B, Cox WI, Barness LA. Dietary nucleotide effects upon immune function in infants. Pediatrics 1991;88(2)359-63.
82. Cordle CT, Winship TR, Schaller JP, et al. Immune status of infants fed soy based formulas with or without added nucleotides for 1 year. II. Immune cell populations. J Pediatr Gastroenterol Nutr 2002;34(2):145-53.
83. Pickering LK, Granoff DM, Erickson JR, et al. Modulation of the immune system by human milk and infant formula containing nucleotides. Pediatrics 1998;101(2):242-9.
84. Ostrom KM, Cordle CT, Schaller JP, et al. Immune status of infants fed soy based formulas with or without added nucleotides for 1 year. I. Vaccine responses, and morbidity. J Pediatr Gastroenterol Nutr 2002;34(2):137-44.
85. Yau K-IT, Huang C-B, Chen W, et al. Effect of nucleotides on diarrhoea and immune responses in healthy term infants in Taiwan. J Pediatr Gastroenterol Nutr 2003;36:37-43.
86. Gil A, Corral E, Molina MAJA. Effects of the addition of nucleotides to an adapted milk formula on the microbial pattern of faeces in at term newborn infants. J Clin Nutr Gastroenterol 1986;1:127-32.
87. Balmer SE, Hanvey LS, Wharton BA. Diet and faecal flora in the newborn: nucleotides. Arch Dis Child Fetal Neonatal Ed 1994;70(2):F137.
88. Sanchez-Pozo A, Pita ML, Martinez A, Molina JA, Sanchez-Medina F, Gil A. Effects of dietary nucleotides upon lipoprotein pattern of newborn infants. Nutr Res 1986; 6:763-71.
89. Sanchez-Pozo A, Morillas J, Molto L, Robles R, Gil A. Dietary nucleotides influence lipoprotein metabolism in newborn infants. Pediatr Res 1994;35(1):112-6.
90. Gil A, Lozano E, De-Lucchi C, Maldonado J, Molina JA, Pita M. Changes in the fatty acid profiles of plasma lipid fractions induced by dietary nucleotides in infants born at term. Eur J Clin Nutr 1988;42(6):473-81.
91. DeLucchi C, Pita ML, Faus MJ, Molina JA, Uauy R, Gil A. Effects of dietary nucleotides on the fatty acid composition of erythrocyte membrane lipids in term infants. J Pediatr Gastroenterol Nutr 1987;6(4):568-74.
92. Brunser O, Espinoza J, Araya M, Cruchet S, Gil A. Effects of dietary nucleotide supplementation on diarrhoeal disease in infants. Acta Paediatr 1994;83(2):188-91.
93. Kunz C, Rudloff S. Biological functions of oligosaccharides in human milk. Acta Paediatr 1993;82(11):903-12.
94. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000; 30(1):61-7.
95. Nagendra AR, Viswanatha S, Arun Kumar S, Murthy BK, Venkat Rao S. Effect of feeding milk formula containing lactulose to infants on faecal bifidobacterial flora. Nutr Res 1995;15:15-24.
96. Rueda R, Sabatel JL, Maldonado J, Molina-Font JA, Gil A. Addition of gangliosides to an adapted milk formula modifies levels of fecal Escherichia coil in preterm newborn infants. J Pediatr 1998;133(1):90-4.
97. Boehm G, Lidestri M, Casetta P, et al. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed 2002;86(3):F178.
98. Moro G, Minoli I, Mosca M, et al. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr 2002;34(3): 291-5.
99. Schmelzle H, Wirth S, Skopnik H, et al. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr 2003;36(3): 343-51.
100. Knol J, Steenbakker GMA, van der Linde EGM, et al. Bifidobacterial species that are present in breast fed infants are stimulate and in formula fed infants by changing to a formula containing prebiotics. J Pediatr Gastroenterol Nutr 2002;34(4):477.
101. European Commission Scientific Committee on Food. Additional statement on the use of resistant short chain carbohydrates (oligofructosyl-saccharose and oligogalactosyl-lactose) in infant formulae and in follow-on formulae. SCF/CS.NUT/IF/47 Final. 14 December 2001.
102. Guesry PR, Bodanski H, Tornsit E, Aeschlimann JM. Effect of 3 doses of fructo-oligosaccharides in infants. J Pediatr Gastroenterol Nutr 2000;31(2):S252.
103. Langhenddes JP, Detry J, Van Hees J, et al. Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr 1995;21(2):177-81.
104. de Roos NM, Katan MB. Effects of probiotic bacteria on diarrhoea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr 2000;71(2):405-11.
105. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhoea in children: a meta-analysis. Pediatrics 2002;109(4):678-4.
106. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhoea in children: a meta-analysis. Dig Dis Sci 2002;47(11):2625-34.
107. Oberhelman RA, Gilman RH, Sheen P, et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhoea in undernourished Peruvian children. J Pediatr 1999;134(1): 15-20.
108. Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhoea in infants. J Pediatr 2001;138(3): 361-5.
109. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhoea in children. J Pediatr 1999;135(5):564-8.
110. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhoea in children with respiratory infections: a randomized study. Pediatrics 1999;104(5):e64.
111. Hatakka K, Savilahti E, Ponka A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomized trial. BMJ 2001;322(7298):1327.
112. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001;107(1):129-34.
113. Kirjavainen PV, Apostolou E, Arvola T, Salminen SJ, Gibson GR, Isolauri E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 2001; 32(1):1-7.
114. Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 2002;51(1): 51-5.
115. Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. Difference in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 2001;108(1):144-5.
116. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99(2):179-85.
117. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30(11):1604-10.
118. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001;357(9262):1076-9.
119. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002;109(1):119-21.
120. Committee on Medical Aspects of Food and Nutrition. Guidelines on the nutritional assessment of infant formulas. Report on health and social subjects No. 47. London: HMSO, 1996.
121. Aggett PJ, Agostini C, Goulet O, et al. The nutritional and safety assessment of breast milk substitutes and other dietary products for infants: a commentary by the espghan committee on nutrition. J Pediatr Gastroenterol Nutr 2001;32(3):256-8.
122. IDACE position on claims in annex IV for infant formulae (proposal for modification of Council Directive 91/321/EEC). REF 01/071. 2001.
123. Aggett P, Agostoni C, Axelsson I, et al. Core data for nutrition trials in infants: a discussion document-a commentary by the espghan committee on nutrition. J Pediatr Gastroenterol Nutr 2003;36(3):338-42.